Different concentrations of nivolumab reduce PD-1 expression but not tumour growth in an EMT6 mouse model

Different concentrations of nivolumab reduce PD-1 expression but not tumour growth in an EMT6 mouse model

Introduction: The interaction between the T cell immune checkpoint proteins, the programmed death-1 (PD -1) receptor, and its ligand PD -L1 plays a crucial role in T cell suppression and the evasion of cancer cells from immune detection, thereby promoting tumour growth. Nivolumab, a PD -1 inhibitor,...

Full description

Bibliographic Details
Published in:BIOMEDICAL RESEARCH AND THERAPY
Main Authors: Sham, Nur Fatihah Ronny; Hasbullah, Harissa Husainy; Hasani, Narimah Abdul Hamid; Hasan, Nurhaslina; Othman, Suraya; Osman, Nora Julianna; Karim, Muhammad Khalis Abdul; Fuad, Syed Baharom Syed Ahmad; Ibahim, Mohammad Johari
Format: Article
Language:English
Published: BIOMEDPRESS 2024
Subjects:
Research & Experimental Medicine
Online Access:https://www-webofscience-com.uitm.idm.oclc.org/wos/woscc/full-record/WOS:001181825100001

Internet

https://www-webofscience-com.uitm.idm.oclc.org/wos/woscc/full-record/WOS:001181825100001

Similar Items